TY - JOUR
T1 - Bioactive exopolysaccharide-composites based on gold and silver nanoparticles tailored for wound healing
AU - Concórdio-Reis, Patrícia
AU - Ramos, Kleyde
AU - Macedo, Ana Catarina
AU - Serra, Ana Teresa
AU - Moppert, Xavier
AU - Guézennec, Jean
AU - Sevrin, Chantal
AU - Grandfils, Christian
AU - Reis, Maria A. M.
AU - Freitas, Filomena
N1 - Funding Information:
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04378%2F2020/PT#
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04462%2F2020/PT#
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04462%2F2020/PT
info:eu-repo/grantAgreement/FCT/OE/SFRH%2FBD%2F131947%2F2017/PT#
Project LA/P/0140/202019 of the Associate Laboratory Institute for Health and Bioeconomy - i4HB. iNOVA4Health—and the Associate Laboratories LS4FUTURE (LA/P/0087/2020) are also acknowledged. Funding from INTERFACE Programme, through the Innovation, Technology and Circular Economy Fund (FITEC), is gratefully acknowledged. ATS also acknowledges FCT/MCTES for the Individual Grant CEEC-IND/04801/2017. Patrícia Concórdio-Reis: Conceptualization, Writing – original draft, Methodology, Data analysis. Kleyde Ramos: Methodology, Data analysis. Ana Catarina Macedo: Methodology, Data analysis. Ana Teresa Serra: Writing – review & editing, Supervision. Chantal Sevring: Methodology, Data analysis. Xavier Moppert: Methodology, Data analysis. Christian Grandfils: Writing – review & editing, Supervision. Maria A.M. Reis: Writing – review & editing, Supervision. Filomena Freitas: Conceptualization, Writing – review & editing, Supervision. Jean Guézennec: Writing – review & editing, Supervision. All authors have read and agreed to the published version of the manuscript.
Funding Information:
This work was financed by national funds from FCT - Fundaç ão para a Ciência e a Tecnologia, I.P., in the scope of the projects UIDP/04378/2020 and UIDB/04378/2020 of the Research Unit on Applied Molecular Biosciences – UCIBIO and project LA/P/0140/202019 of the Associate Laboratory Institute for Health and Bioeconomy - i4HB. iNOVA4Health — and the Associate Laboratories LS4FUTURE (LA/P/0087/2020) are also acknowledged. Funding from INTERFACE Programme, through the Innovation, Technology and Circular Economy Fund ( FITEC ), is gratefully acknowledged. ATS also acknowledges FCT/MCTES for the Individual Grant CEEC-IND/04801/2017 .
Publisher Copyright:
© 2023 Elsevier Ltd
PY - 2023/3
Y1 - 2023/3
N2 - The marine isolate Alteromonas macleodii Mo 169 secretes a exopolysaccharide (EPS) mainly composed of glucuronic acid and containing sulphate, pyruvate, and lactate as acyl substituents. The high density of negatively charged functional groups of the EPS renders it the ability to function as a stabilizing and reducing agent for the synthesis of metallic nanoparticles (NP). In this study, silver and gold NP (AgNP and AuNP, respectively) were successfully synthesized and stabilized by A. macleodii Mo 169 EPS. The obtained AuNP and AgNP presenting a spherical shape with an average particle size of 16 and 15 nm, respectively, displaying a polysaccharide layer that apparently contributed to reduce their aggregation. The cytotoxicity of the EPS and the bio-nanocomposites was evaluated on human keratinocyte (HaCaT) and fibroblast (CCD-1079Sk) cell lines. None of the samples demonstrated cytotoxicity for concentrations up to 1000 mg L−1. In vitro wound healing experiments demonstrated that both bio-nanocomposites promoted cell migration for concentrations above 100 mg L−1, thus contributing for a faster wound recovery. These findings demonstrate for the first time the potential of A. macleodii Mo169 EPS to synthesize and stabilize nanoparticles that possess promising physical-chemical and biological characteristics that render them valuable for the development of novel biomaterials for several applications, including wound care.
AB - The marine isolate Alteromonas macleodii Mo 169 secretes a exopolysaccharide (EPS) mainly composed of glucuronic acid and containing sulphate, pyruvate, and lactate as acyl substituents. The high density of negatively charged functional groups of the EPS renders it the ability to function as a stabilizing and reducing agent for the synthesis of metallic nanoparticles (NP). In this study, silver and gold NP (AgNP and AuNP, respectively) were successfully synthesized and stabilized by A. macleodii Mo 169 EPS. The obtained AuNP and AgNP presenting a spherical shape with an average particle size of 16 and 15 nm, respectively, displaying a polysaccharide layer that apparently contributed to reduce their aggregation. The cytotoxicity of the EPS and the bio-nanocomposites was evaluated on human keratinocyte (HaCaT) and fibroblast (CCD-1079Sk) cell lines. None of the samples demonstrated cytotoxicity for concentrations up to 1000 mg L−1. In vitro wound healing experiments demonstrated that both bio-nanocomposites promoted cell migration for concentrations above 100 mg L−1, thus contributing for a faster wound recovery. These findings demonstrate for the first time the potential of A. macleodii Mo169 EPS to synthesize and stabilize nanoparticles that possess promising physical-chemical and biological characteristics that render them valuable for the development of novel biomaterials for several applications, including wound care.
KW - Alteromonas macleodii Mo 169
KW - Bioactive material
KW - Exopolysaccharide (EPS)
KW - Gold nanoparticles (AuNP)
KW - Silver nanoparticles (AgNP)
UR - http://www.scopus.com/inward/record.url?scp=85146432819&partnerID=8YFLogxK
U2 - 10.1016/j.mtcomm.2023.105351
DO - 10.1016/j.mtcomm.2023.105351
M3 - Article
AN - SCOPUS:85146432819
SN - 2352-4928
VL - 34
JO - Materials Today Communications
JF - Materials Today Communications
M1 - 105351
ER -